Skip to main content
SpringerLink
Log in

The under-use of Β-blockers for treating chronic heart failure (HF) might be explained by the deteriorations associated with advanced disease.

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Lainscak M, Wieczorek P, Moullet C, Klimek K, Tendera M.Why do we fail to use adequate doses of beta blockers in daily practice in patients with chronic heart failure? Findings from the satellite survey. ESC Congress 2008: Annual Congress of the European Society of Cardiology: abstr. P1958, 30 Aug 2008. Available from: URL: http://www.escardio.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The under-use of Β-blockers for treating chronic heart failure (HF) might be explained by the deteriorations associated with advanced disease.. Pharmacoecon. Outcomes News 561, 8 (2008). https://doi.org/10.2165/00151234-200805610-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805610-00018

Keywords

Search

Navigation